We're taking a closer look at Vertex Pharmaceuticals today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -3.3% compared to 0.0% for the S&P ...
Shares of Vertex Pharmaceuticals ... session for the stock market, with the S&P 500 Index SPX rising 0.56% to 6,032.38 and the Dow Jones Industrial Average DJIA rising 0.42% to 44,910.65.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Vertex currently has a Zacks ...
They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do ...
Over the years, we’ve had good success recommending stocks that have tanked on news of a significant sale by a major shareholder. That’s because due to the sizable [...] ...
In this piece, we will look at where Vertex Pharmaceuticals Incorporated ... recently updated its long-term forecasts for the US stock market. In a research report titled ‘Global Strategy ...
On Thursday, BofA issued a cautionary note on Vertex Pharmaceuticals (NASDAQ:VRTX), citing concerns that the biotech company's stock may be poised for a downturn after forming a potential "double top" ...